Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$695K Sell
6,755
-13,248
-66% -$1.43M 0.56% 37
2023
Q2
$2.31M Sell
20,003
-340
-2% -$38.6K 0.38% 51
2023
Q1
$2.16M Buy
20,343
+166
+0.8% +$17.9K 0.41% 52
2022
Q4
$2.24M Sell
20,177
-14,084
-41% -$1.44M 0.46% 42
2022
Q3
$2.95M Buy
34,261
+8,494
+33% +$758K 0.59% 27
2022
Q2
$2.35M Buy
25,767
+2,375
+10% +$211K 0.44% 40
2022
Q1
$1.92M Buy
23,392
+1,117
+5% +$88.1K 0.31% 69
2021
Q4
$1.71M Sell
22,275
-7,983
-26% -$636K 0.25% 85
2021
Q3
$2.27M Buy
30,258
+1,218
+4% +$92.6K 0.35% 60
2021
Q2
$2.26M Buy
29,040
+1,215
+4% +$90.4K 0.36% 64
2021
Q1
$2.05M Buy
27,825
+3,392
+14% +$250K 0.38% 63
2020
Q4
$1.91M Buy
24,433
+13,139
+116% +$1M 0.39% 55
2020
Q3
$894K Sell
11,294
-9,190
-45% -$720K 0.62% 38
2020
Q2
$1.51M Buy
20,484
+2,923
+17% +$220K 0.39% 63
2020
Q1
$1.29M Buy
17,561
+8,452
+93% +$664K 0.4% 56
2019
Q4
$732K Hold
9,109
0.26% 103
2019
Q3
$732K Buy
9,109
+311
+4% +$24.9K 0.26% 103
2019
Q2
$699K Buy
8,798
+2,185
+33% +$167K 0.27% 98
2019
Q1
$472K Buy
6,613
+907
+16% +$67.8K 0.19% 131
2018
Q4
$413K Sell
5,706
-82
-1% -$5.79K 0.21% 120
2018
Q3
$390K Buy
5,788
+28
+0.5% +$1.78K 0.18% 140
2018
Q2
$341K Buy
5,760
+155
+3% +$8.74K 0.19% 131
2018
Q1
$287K Buy
5,605
+47
+0.8% +$2.54K 0.15% 153
2017
Q4
$328K Buy
5,558
+1,127
+25% +$62.5K 0.17% 141
2017
Q3
$271K Buy
4,431
+2
+0% +$121 0.14% 147
2017
Q2
$271K Sell
4,429
-2,498
-36% -$152K 0.13% 148
2017
Q1
$421K Buy
6,927
+2,974
+75% +$180K 0.26% 107
2016
Q4
$222K Sell
3,953
-1,657
-30% -$97K 0.16% 152
2016
Q3
$335K Buy
5,610
+36
+0.6% +$2.1K 0.27% 110
2016
Q2
$307K Buy
5,574
+1,179
+27% +$62.7K 0.25% 114
2016
Q1
$224K Buy
+4,395
New +$215K 0.18% 131

Other funds holding MRK

V Wealth Advisors's MRK Position: Q3 2023 in Review

V Wealth Advisors reduced its Merck (MRK) stake by 66% in Q3 2023, selling an estimated $1.43M and leaving 6,755 shares worth $695K. The position accounts for 0.56% of the portfolio, ranked #37.

V Wealth Advisors first reported a position in MRK in Q1 2016 and has held it in 31 quarters since. The position peaked at $2.95M in Q3 2022. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • V Wealth Advisors held 6,755 shares of Merck worth $695K as of Q3 2023.
  • V Wealth Advisors sold 13,248 Merck shares in Q3 2023, an estimated $1.43M.
  • Merck made up 0.56% of V Wealth Advisors's portfolio in Q3 2023, its #37 holding.
  • V Wealth Advisors first reported a position in Merck in Q1 2016 and has held it in 31 quarters since.
  • V Wealth Advisors's Merck position peaked at $2.95M in Q3 2022.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on V Wealth Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.